AIG
STLN

American International Group’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

American International Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,324
Closed -$11.7K – 3166
2023
Q1 		$11.7K Buy
17,324
+865
+5% +$1.1K ﹤0.01% 2939
2022
Q4 		$27.2K Sell
16,459
-59
-0.4% -$166 ﹤0.01% 2882
2022
Q3 		$76K Buy
16,518
+7,728
+88% +$45.4K ﹤0.01% 2681
2022
Q2 		$44K Buy
+8,790
New +$64K ﹤0.01% 2900

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's STLN Position: Q2 2023 in Review

American International Group sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2023, closing a stake of 17,324 shares — an estimated $11.7K sold.

American International Group first reported a position in STLN in Q2 2022 and held it in 4 quarters. The position peaked at $76K in Q3 2022. 38 funds tracked by Wall St. Rank hold STLN as of Q2 2023.

  • American International Group reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 17,324 Starling Oncology Institute, Inc. Common Stock shares in Q2 2023, an estimated $11.7K.
  • American International Group first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • American International Group's Starling Oncology Institute, Inc. Common Stock position peaked at $76K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.